EGFR and neoplasm: EGFR activates mTORC1 via the PI3K/AKT pathway, upregulating glutaminase (GLS) to fuel nucleotide synthesis, while STAT3-mediated cell cycle progression creates a self-reinforcing loop that provides both biosynthetic precursors and proliferative signals for rapid tumor growth (51, 52).